Jim Cramer's Lightning Round: Affirm, Eli Lilly, ServiceNow, and More

Stock Picks and Market Overreactions

• 💡 Jim Cramer discusses the market's reaction to weaker-than-expected data, suggesting it may have overreacted.
• 🎯 He addresses concerns about Eli Lilly's handling of a drug trial, expressing personal upset despite acknowledging the stock's potential.

Affirm: A Bullish Outlook

• 🚀 Cramer strongly recommends getting on board with Affirm, a buy now, pay later company.
• 💰 He cites Affirm's strong past performance and anticipates confirmation of his bullish view in upcoming quarterly earnings.

International Banking and Insurance

• 🏦 Regarding Bank of Montreal (BBG), Cramer prefers Santander as an overseas bank investment, highlighting its strength in Europe.
• 💡 For insurance stocks, he favors Lemonade over Root, believing Lemonade is disrupting the industry and could lead to lower rates.

ServiceNow: Short-Term vs. Long-Term

• ⚠️ Cramer notes that ServiceNow is facing short-term pressure due to concerns about its subscription model being impacted by AI.
• ✅ However, he remains bullish on ServiceNow long-term, citing its strong AI capabilities and advising against betting against the stock.